Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study (Q41517903)
Jump to navigation
Jump to search
scientific article published on 22 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study |
scientific article published on 22 January 2015 |
Statements
1 reference
Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study (English)
1 reference
Robert Landewé
1 reference
Josef S Smolen
1 reference
Jonathan Kay
1 reference
Mittie Doyle
1 reference
Eric L Matteson
1 reference
Norman Gaylis
1 reference
Jürgen Wollenhaupt
1 reference
Frederick T Murphy
1 reference
Stephen Xu
1 reference
Yiying Zhou
1 reference
Elizabeth C Hsia
1 reference
1 reference
22 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference